JLHLBSEJupiter Life Line Hospitals LtdMinimalNeutral
Announced Sun, 17 May · 10:15 IST

Newspaper Publication for Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.2%1-day move
₹1323.00
prior close
₹1335.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.9-2.2-2.6-2.9+1.2-0.2-1.2+2.7+2.6+0.2+1.5+1.9+17.8
Up moveDown movePending
AI summary

Jupiter Life Line Hospitals published its audited full-year (FY2026) and unaudited Q4 FY2026 financial results in Financial Express and Pudhari newspaper on May 17, 2026. Consolidated revenue grew 15.2% to Rs 14,997.87 million from Rs 13,024.02 million in FY2025. Standalone revenue rose 13% to Rs 11,976.24 million. Consolidated net profit after tax was largely flat at Rs 1,941.87 million vs Rs 1,937.54 million, with net profit margin compressing despite revenue growth. EPS stood at Rs 29.59 (consolidated) for the year. The Board declared an interim dividend of Rs 1 per equity share (face value Rs 10) for FY2025-26. Results were approved by the Board on May 15, 2026.

Likely market impact

Revenue growth is strong at ~15%, but flat net profit suggests margin pressure in FY2026. The interim dividend is a modest positive for income-focused investors. The discrepancy between consolidated and standalone profit warrants closer review when the full detailed filing is available.